These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 26115766)

  • 1. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
    Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
    Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Engineered Galactosylceramidase Construct Improves AAV Gene Therapy for Krabbe Disease in Twitcher Mice.
    Pan X; Sands SA; Yue Y; Zhang K; LeVine SM; Duan D
    Hum Gene Ther; 2019 Sep; 30(9):1039-1051. PubMed ID: 31184217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease.
    Heller GJ; Marshall MS; Issa Y; Marshall JN; Nguyen D; Rue E; Pathmasiri KC; Domowicz MS; van Breemen RB; Tai LM; Cologna SM; Crocker SJ; Givogri MI; Sands MS; Bongarzone ER
    Mol Ther; 2021 May; 29(5):1883-1902. PubMed ID: 33508430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
    Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
    Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy.
    Feltri ML; Weinstock NI; Favret J; Dhimal N; Wrabetz L; Shin D
    Glia; 2021 Oct; 69(10):2309-2331. PubMed ID: 33851745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes.
    Mangiameli E; Cecchele A; Morena F; Sanvito F; Matafora V; Cattaneo A; Della Volpe L; Gnani D; Paulis M; Susani L; Martino S; Di Micco R; Bachi A; Gritti A
    Stem Cell Reports; 2021 Jun; 16(6):1478-1495. PubMed ID: 33989519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Improvement of Neurological Signs and Metabolic Dysfunction in a Mouse Model of Krabbe's Disease after Global Gene Therapy.
    Marshall MS; Issa Y; Jakubauskas B; Stoskute M; Elackattu V; Marshall JN; Bogue W; Nguyen D; Hauck Z; Rue E; Karumuthil-Melethil S; Zaric V; Bosland M; van Breemen RB; Givogri MI; Gray SJ; Crocker SJ; Bongarzone ER
    Mol Ther; 2018 Mar; 26(3):874-889. PubMed ID: 29433937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic cell transplantation in murine globoid cell leukodystrophy (the twitcher mouse): effects on levels of galactosylceramidase, psychosine, and galactocerebrosides.
    Ichioka T; Kishimoto Y; Brennan S; Santos GW; Yeager AM
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4259-63. PubMed ID: 2884662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages Expressing GALC Improve Peripheral Krabbe Disease by a Mechanism Independent of Cross-Correction.
    Weinstock NI; Shin D; Dhimal N; Hong X; Irons EE; Silvestri NJ; Reed CB; Nguyen D; Sampson O; Cheng YC; Lau JTY; Bongarzone ER; Kofler J; Escolar ML; Gelb MH; Wrabetz L; Feltri ML
    Neuron; 2020 Jul; 107(1):65-81.e9. PubMed ID: 32375064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease.
    Li Y; Miller CA; Shea LK; Jiang X; Guzman MA; Chandler RJ; Ramakrishnan SM; Smith SN; Venditti CP; Vogler CA; Ory DS; Ley TJ; Sands MS
    Mol Ther; 2021 Feb; 29(2):691-701. PubMed ID: 33388420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The twitcher mouse. Central nervous system pathology after bone marrow transplantation.
    Suzuki K; Hoogerbrugge PM; Poorthuis BJ; Bekkum DW; Suzuki K
    Lab Invest; 1988 Mar; 58(3):302-9. PubMed ID: 3279262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation.
    Hoogerbrugge PM; Suzuki K; Suzuki K; Poorthuis BJ; Kobayashi T; Wagemaker G; van Bekkum DW
    Science; 1988 Feb; 239(4843):1035-8. PubMed ID: 3278379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.
    Reddy AS; Patel JR; Vogler C; Klein RS; Sands MS
    PLoS One; 2014; 8(6):e64647. PubMed ID: 23755134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for Krabbe's disease: Finding the combination.
    Mikulka CR; Sands MS
    J Neurosci Res; 2016 Nov; 94(11):1126-37. PubMed ID: 27638598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic cell genetic analysis of the galactocerebrosidase gene: lack of complementation in human Krabbe disease/twitcher mouse cell hybrids.
    Skiba MC; Lyerla TA; Konola JT; Raghavan S
    J Neurosci Res; 1990 Dec; 27(4):472-8. PubMed ID: 2079710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic cell transplantation after administration of high-dose busulfan in murine globoid cell leukodystrophy (the twitcher mouse).
    Yeager AM; Shinohara M; Shinn C
    Pediatr Res; 1991 Mar; 29(3):302-5. PubMed ID: 2034480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and morphological studies of dorsal root ganglion and its cultured cells from twitcher mouse (murine globoid cell leukodystrophy).
    Ida H; Eto Y
    Brain Dev; 1990; 12(4):412-6. PubMed ID: 2240461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-specific ablation of the Krabbe disease gene galactosylceramidase in mice results in neurodegeneration.
    Kreher C; Favret J; Weinstock NI; Maulik M; Hong X; Gelb MH; Wrabetz L; Feltri ML; Shin D
    PLoS Biol; 2022 Jul; 20(7):e3001661. PubMed ID: 35789331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination HSCT and intravenous AAV-mediated gene therapy in a canine model proves pivotal for translation of Krabbe disease therapy.
    Bradbury AM; Bagel J; Swain G; Miyadera K; Pesayco JP; Assenmacher CA; Brisson B; Hendricks I; Wang XH; Herbst Z; Pyne N; Odonnell P; Shelton GD; Gelb M; Hackett N; Szabolcs P; Vite CH; Escolar M
    Mol Ther; 2024 Jan; 32(1):44-58. PubMed ID: 37952085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The twitcher mouse: degeneration of oligodendrocytes in vitro.
    Nagara H; Ogawa H; Sato Y; Kobayashi T; Suzuki K
    Brain Res; 1986 Apr; 391(1):79-84. PubMed ID: 3513905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.